(Q35730252)

9 August 2017

1 reference

title

Crosstalk between angiogenesis and lymphangiogenesis in tumor progression (English)

1 reference

9 August 2017

1 reference

1 reference

Scavelli C

1

1 reference

9 August 2017

Vacca A

2

1 reference

9 August 2017

Di Pietro G

3

1 reference

9 August 2017

Dammacco F

4

1 reference

9 August 2017

Ribatti D

5

1 reference

9 August 2017

1 June 2004

1 reference

9 August 2017

1 reference

9 August 2017

18

1 reference

9 August 2017

6

1 reference

9 August 2017

1054-1058

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403355

9 August 2017

0 references

cites work

Structure of platelet-derived growth factor: implications for functional properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

The Angiogenic and Lymphangiogenic Factor Vascular Endothelial Growth Factor-D Exhibits a Paracrine Mode of Action in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Structure, function, and molecular control of the skin lymphatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

7 January 2021

Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

7 January 2021

Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

7 January 2021

Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

7 January 2021

Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

7 January 2021

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403355

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403355

1 reference

9 August 2017

1 reference